Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Head of Discovery, Large Molecule Research, Roche Pharma Research and Early Development at Roche Innovation Center Munich
Martin Steegmaier is Roche pRED’s (Roche Pharma Research & Early Development) Head of Discovery in Large Molecule Research at the Roche Innovation Center Munich in Germany. Martin earned his PhD in biochemistry from the University of Basel, Switzerland. Before joining the pharmaceutical industry he spent four years as a postdoctoral research fellow at Stanford University Medical School elucidating the biochemical mechanisms underlying neurotransmitter secretion and other vesicle trafficking events. In 2000, he joined Boehringer Ingelheim’s Oncology Drug Discovery Department and held positions with increasing responsibility. In 2006, he transitioned to Roche and held a number of positions before he was nominated Head of Discovery in Large Molecule Research in Roche pRED in March 2012.